Viewing Study NCT00283634


Ignite Creation Date: 2025-12-25 @ 2:36 AM
Ignite Modification Date: 2026-01-05 @ 8:43 PM
Study NCT ID: NCT00283634
Status: TERMINATED
Last Update Posted: 2011-02-17
First Post: 2006-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-08
Start Date Type: None
Primary Completion Date: 2007-07
Primary Completion Date Type: ACTUAL
Completion Date: 2007-08
Completion Date Type: ACTUAL
First Submit Date: 2006-01-27
First Submit QC Date: None
Study First Post Date: 2006-01-30
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-02-16
Last Update Post Date: 2011-02-17
Last Update Post Date Type: ESTIMATED